Mark R. Hurtt
Keine laufenden Positionen mehr
Profil
Mark R.
Hurtt has been Chief Medical Officer of Alseres Pharmaceuticals, Inc. since October 2005.
Previously, he was Senior Director-Clinical Research of Neurogen Corporation, Director-Drug Development and Director-Clinical Research of Pfizer Global Research and Development and Assistant Professor of Neurology and Pathology at the University of Pittsburgh.
Dr. Hurtt received an MD degree from Jefferson Medical College
Ehemalige bekannte Positionen von Mark R. Hurtt
Unternehmen | Position | Ende |
---|---|---|
University of Pittsburgh | Corporate Officer/Principal | - |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Technik-/Wissenschafts-/F&E-Leiter | - |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Technik-/Wissenschafts-/F&E-Leiter | - |
ALSERES PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Mark R. Hurtt
Sidney Kimmel Medical College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ALSERES PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |